18578966. PREFUSION-STABILIZED CHIMERIC HMPV-RSV F PROTEINS simplified abstract (Board of Regents, The University of Texas System)
Contents
PREFUSION-STABILIZED CHIMERIC HMPV-RSV F PROTEINS
Organization Name
Board of Regents, The University of Texas System
Inventor(s)
Jason Mclellan of Austin TX (US)
Ching-Lin Hsieh of Austin TX (US)
PREFUSION-STABILIZED CHIMERIC HMPV-RSV F PROTEINS - A simplified explanation of the abstract
This abstract first appeared for US patent application 18578966 titled 'PREFUSION-STABILIZED CHIMERIC HMPV-RSV F PROTEINS
- Simplified Explanation:**
The patent application discusses chimeric hMPV/RSV F proteins that show improved stability and expression. These proteins can be used in diagnostics, screening platforms, and vaccine compositions.
- Key Features and Innovation:**
- Chimeric hMPV/RSV F proteins with enhanced stability and expression.
- Potential use in diagnostics, screening platforms, and vaccines.
- Potential Applications:**
The technology can be applied in:
- Diagnostics for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
- Screening platforms for drug discovery.
- Vaccine compositions for RSV and hMPV.
- Problems Solved:**
- Addressing the need for stable and highly expressed F proteins for RSV and hMPV.
- Improving the efficacy of diagnostics and vaccines for these viruses.
- Benefits:**
- Enhanced stability and expression of F proteins.
- Improved accuracy in diagnostics.
- Potential for more effective vaccines.
- Commercial Applications:**
- Title: Enhanced Chimeric hMPV/RSV F Proteins for Diagnostics, Screening, and Vaccines
- The technology can be commercialized in the pharmaceutical industry for developing diagnostic kits, screening assays, and vaccine formulations for RSV and hMPV.
- Questions about Chimeric hMPV/RSV F Proteins:**
1. What are the specific advantages of using chimeric hMPV/RSV F proteins in diagnostics and vaccines? 2. How do these chimeric proteins compare to traditional F proteins in terms of stability and expression levels?
Original Abstract Submitted
Provided herein are chimeric hMPV/RSV F proteins. In some aspects, the chimeric hMPV/RSV F proteins exhibit enhanced conformational stability, enhanced thermostability, and/or increased expression. Methods are also provided for use of the chimeric F proteins as diagnostics, in screening platforms, and/or in vaccine compositions.